|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Malaria | |||||
| 2 | More general conditions related to this trial | ||||
| Coccidiosis | |||||
| Parasitic Diseases | |||||
| Protozoan Infections | |||||
| 3 | Interventions listed in this trial | ||||
| RTS,S with AS02A/AS01B adjuvant | |||||
| 4 | Sponsors listed in this trial | ||||
| U.S. Army Office of the Surgeon General | |||||
| GlaxoSmithKline | |||||